How Reproducible Are QM/MM Simulations? Lessons from Computational Studies of the Covalent Inhibition of the SARS-CoV-2 Main Protease by Carmofur

被引:12
|
作者
Giudetti, Goran [1 ]
Polyakov, Igor [2 ]
Grigorenko, Bella L. [2 ]
Faraji, Shirin [3 ]
Nemukhin, Alexander V. [2 ]
Krylov, Anna I. [1 ]
机构
[1] Univ Southern Calif, Dept Chem, Los Angeles, CA 90089 USA
[2] Lomonosov Moscow State Univ, Dept Chem, Moscow 119991, Russia
[3] Univ Groningen, Zernike Inst Adv Mat, NL-9747 Groningen AG, Netherlands
基金
美国国家科学基金会; 荷兰研究理事会; 俄罗斯科学基金会;
关键词
QUANTUM MECHANICS/MOLECULAR MECHANICS; REDISTRIBUTED CHARGE; DENSITY FUNCTIONALS; MOLECULAR-DYNAMICS; PROTON-TRANSFER; FREE-ENERGY; CYSTEINE; BINDING; ENVIRONMENT; SCHEMES;
D O I
10.1021/acs.jctc.2c00286
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This work explores the level of transparency in reporting the details of computational protocols that is required for practical reproducibility of quantum mechanics/molecular mechanics (QM/MM) simulations. Using the reaction of an essential SARS-CoV-2 enzyme (the main protease) with a covalent inhibitor (carmofur) as a test case of chemical reactions in biomolecules, we carried out QM/MM calculations to determine the structures and energies of the reactants, the product, and the transition state/intermediate using analogous QM/MM models implemented in two software packages, NWChem and Q-Chem. Our main benchmarking goal was to reproduce the key energetics computed with the two packages. Our results indicate that quantitative agreement (within the numerical thresholds used in calculations) is difficult to achieve. We show that rather minor details of QM/ MM simulations must be reported in order to ensure the reproducibility of the results and offer suggestions toward developing practical guidelines for reporting the results of biosimulations.
引用
收藏
页码:5056 / 5067
页数:12
相关论文
共 50 条
  • [21] Computational fragment screening of dimeric SARS-CoV-2 main protease
    Reid, Rashad L.
    Voelz, Vincent
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 182A - 182A
  • [22] Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide
    Yamane, Daiki
    Onitsuka, Satsuki
    Re, Suyong
    Isogai, Hikaru
    Hamada, Rui
    Hiramoto, Tadanari
    Kawanishi, Eiji
    Mizuguchi, Kenji
    Shindo, Naoya
    Ojida, Akio
    CHEMICAL SCIENCE, 2022, 13 (10) : 3027 - 3034
  • [23] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    ANTIVIRAL RESEARCH, 2024, 225
  • [24] Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2
    Paul, Archi Sundar
    Islam, Rajib
    Parves, Md Rimon
    Al Mamun, Abdulla
    Shahriar, Imrul
    Hossain, Md Imran
    Hossain, Md Nayeem
    Ali, Md Ackas
    Halim, Mohammad A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (04): : 1639 - 1658
  • [25] Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
    Liu, Sen
    Zheng, Qiang
    Wang, Zhiying
    BIOINFORMATICS, 2020, 36 (11) : 3295 - 3298
  • [26] Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease
    Roy, Rajarshi
    Sk, Md Fulbabu
    Tanwar, Omprakash
    Kar, Parimal
    MOLECULAR DIVERSITY, 2023, 27 (04) : 1587 - 1602
  • [27] Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease
    Durgam, Laxman
    Guruprasad, Lalitha
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (09): : 3741 - 3751
  • [28] Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease
    Rajarshi Roy
    Md Fulbabu Sk
    Omprakash Tanwar
    Parimal Kar
    Molecular Diversity, 2023, 27 (4) : 1587 - 1602
  • [29] Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
    Atatreh, Noor
    Mahgoub, Radwa E.
    Ghattas, Mohammad A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [30] Investigating the Inhibition of Diindolylmethane Derivatives on SARS-CoV-2 Main Protease
    Li, Wenjin
    Chang, Xiaoyu
    Zhou, Hang
    Yu, Wenquan
    Wang, Ruiyong
    Chang, Junbiao
    JOURNAL OF MOLECULAR RECOGNITION, 2024, 37 (06)